PP_1170x120_10-25-21

oxcarbazepine tablets

Camber Pharma launches generic Trilepta

Camber Pharma launches generic Trilepta

PISCATAWAY,  N.J. – Camber Pharmaceuticals announces the addition of oxcarbazepine tablets to their current portfolio. Oxcarbazepine tablets are indicated in use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients